86K0J5AK6M 391210-10-9 PD-0325901 Mirdametinib [USAN] Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- PD 0325901 PD 325901 PD0325901 PD-325901 UNII-86K0J5AK6M Mirdametinib WHO 11299 CAS 391210-10-9

Purity 97%+In StockPharmaceutical Standards
CAS No.391210-10-9
Molecular FormulaC16H14F3IN2O4
Molecular Weight482.19 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

86K0J5AK6M 391210-10-9 PD-0325901 Mirdametinib [USAN] Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- PD 0325901 PD 325901 PD0325901 PD-325901 UNII-86K0J5AK6M Mirdametinib WHO 11299 CAS 391210-10-9 chemical structure

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including 86K0J5AK6M 391210-10-9 PD-0325901 Mirdametinib [USAN] Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- PD 0325901 PD 325901 PD0325901 PD-325901 UNII-86K0J5AK6M Mirdametinib WHO 11299.

CATO supplies 86K0J5AK6M 391210-10-9 PD-0325901 Mirdametinib [USAN] Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- PD 0325901 PD 325901 PD0325901 PD-325901 UNII-86K0J5AK6M Mirdametinib WHO 11299 (CAS 391210-10-9), a certified reference material (molecular formula C16H14F3IN2O4, MW 482.19 g/mol) for analytical method development and quality control.

Structurally, 86K0J5AK6M 391210-10-9 PD-0325901 Mirdametinib [USAN] Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- PD 0325901 PD 325901 PD0325901 PD-325901 UNII-86K0J5AK6M Mirdametinib WHO 11299 (C16H14F3IN2O4) contains a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine/iodine substitution. The molecule exhibits a degree of unsaturation (DBE) of 9.0, corresponding to approximately 9 ring(s) or double-bond equivalent(s). With a molecular weight of 482.19 g/mol, it falls into the moderately-high-molecular-weight range. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.

CATO manufactures 86K0J5AK6M 391210-10-9 PD-0325901 Mirdametinib [USAN] Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- PD 0325901 PD 325901 PD0325901 PD-325901 UNII-86K0J5AK6M Mirdametinib WHO 11299 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC16H14F3IN2O4
Molecular Weight482.19 g/mol
AppearancePale yellow to yellow crystalline powder. (slight halide-like odor, low volatility)
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)9.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)2025
Halogen ContentF/I-containing
Nitrogen Atoms2

Recommended Standards

Why CATO?